The epithelial-to-mesenchymal transition (EMT) is a crucial process, occurring both during development and tumor progression, by which an epithelial cell undergoes a conversion to a mesenchymal phenotype, dissociates from initial contacts and migrates to secondary sites.
Introduction
The epithelial-to-mesenchymal transition (EMT) is a crucial step of tumorigenesis, when non-invasive and non-metastatic tumor cells lose their epithelial phenotype, acquire invasive properties, infiltrate surrounding tissues and metastasize to secondary sites. The most compelling evidence that EMT regulates invasiveness and tumor aggressiveness comes from the observation that markers of EMT are present at the tumor-host interface but not in the bulk tumor [1] [2] [3] [4] . Turning an epithelial cell into a mesenchymal cell requires loss of epithelial polarity, alteration in cellular architecture and acquisition of migration capacity. Hallmarks for EMT include dissolution of cell-cell contacts, production of transcription factors able to inhibit Epithelial cadherin (E-cadherin) expression (e.g. Snail), increased expression of mesenchymal markers (e.g. fibronectin), induction of focal adhesion turnover and secretion of proteolytic enzymes involved in matrix degradation, such as the matrix metalloproteinases (MMPs) [5] .
The multifunctional cytokine Transforming Growth Factor β (TGFβ), which normally functions to prevent the proliferation, regulates differentiation and provokes migration of epithelial cells [6] [7] [8] . TGFβ has also been characterized as an important inducer of EMT [9] via several downstream pathways, including RhoA [10] , Ras/MAPK [11, 12] and Jagged1/ Notch [13] . Furthermore, TGFβ is a regulator of cellular microenvironment and extracellular matrix (ECM) remodeling [14] [15] [16] .
The non-receptor focal adhesion kinase (FAK) is a major protein of the focal adhesion complex that integrates signals from growth factors and integrins to control cell adhesion, migration and invasion [17] . FAK is up-regulated in various epithelial cancers [18] . Moreover, FAK expression correlates with tumor invasiveness [19] and increased FAK activity and/or expression frequently associate with metastatic tumors [20] .
Evidence of FAK implication in the TGFβ-induced EMT is limited to the observation that FAK undergoes to specific phosphorylations during this process [21] ; however, direct evidence of its functional role is yet to be unveiled.
We previously demonstrated that in MMH (Murine Met Hepatocytes) cells TGFβ induces a full EMT characterized by (i) disorganization of epithelial cell membrane and down-regulation of cytoskeleton markers, (ii) decrease of hepatocyte transcriptional factors HNF1 and HNF4 and (iii) up-regulation of mesenchymal and invasiveness markers. We also showed that while Snail over-expression causes down-regulation of epithelial markers, it is not sufficient for the up-regulation of mesenchymal and invasiveness markers [22] . The latter observation suggested that other effectors are necessary for the full accomplishment of the TGFβ-induced EMT of the hepatocyte.
Here, we demonstrate that FAK plays a role in TGFβ-induced up-regulation of EMT mesenchymal and invasiveness markers as well as in the delocalization of membrane-bound E-cadherin.
Materials and methods

Cell lines and culture conditions
MMHs are a number of differentiated, polarized and nontumorigenic hepatocytic cell lines initially described in Amicone et al. [23] . In this work, we used, as MMH parental cell, the epithelial clone described as E14 MMH cell line in Spagnoli and colleagues [24] . MMH-FRNK and MMH-S1034 cells were generated by transfection of parental MMH cells by Lipofectamine 2000 (Invitrogen, San Diego, CA) with pCDNA3.1 FRNK and pCDNA3.1 FRNK-S1034 constructs, respectively. Since pooled populations of transfected hepatocytes were heterogeneous for FRNK and FRNK-S1034 expression (data not shown), several clones were selected and expanded. Two clones that expressed comparable levels of FRNK (clones 1 and 11), and one FRNK-S1034 clone (clone 7) as control, were chosen to examine morphological and biochemical features of the TGFβ-induced EMT.
Cells were grown in RPMI 1640, supplemented with 10% FCS, 50 ng/ml EGF, 30 ng/ml IGF II (PeproTech Inc, Rocky Hill, NJ), 10 μg/ml insulin (Roche, Mannheim, Germany) and antibiotics, using collagen I (Transduction Laboratories, Lexington, UK) coated dishes (Falcon-BD, Franklin Lakes, NJ). For TGFβ treatments, normal medium was supplemented with 2 ng/ml of this cytokine (Gibco BRL, Gaithersburg, MD) for the indicated times. For treatments with pyrazolopyrimidine PP-2 (PP2) (Calbiochem, Merck Chemicals Ltd., Beeston, Nottingham, UK), normal medium was supplemented with 10 μM of this Src inhibitor for the indicated times. PP2 was added 30 min before TGFβ addition.
Immunofluorescence
For indirect immunofluorescence analyses, cells were grown on collagen I-coated 35 mm Ibidi dishes (Ibidi, GmbH Integrated BioDiagnostics, München, Germany) in the absence or presence of TGFβ and/or PP2, fixed and treated as previously described [25] . The antibodies were used as follows: mouse monoclonal anti-E-cadherin antibody (Transduction Laboratories, Lexington, UK) 2.5 μg/ml; rabbit polyclonal anti HNF4α antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 4 μg/ml; mouse monoclonal anti-paxillin antibody (BD Pharmingen Biosciences, San Diego, CA) 5 μg/ml; rabbit polyclonal anti-FAK P-Y 861 phospho-specific antibody (Biosource International, Camarillo, CA) diluted 1/50; rabbit polyclonal anti-FAK P-Y 925 phospho-specific antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 4 μg/ml. Secondary antibodies (Alexa Fluor 488-and 594-labeled, 2 μg/ml and 4 μg/ml respectively) were from Molecular Probes (Invitrogen, San Diego, CA). As control, cells were also treated according to the same protocols only with secondary antibodies (data not shown).
Fluorescence imaging was performed using sequential acquisition of different channels on a Leica TCS2 confocal microscope.
Immunoprecipitations and Western blotting
Cells were lysed on ice in lysis buffer containing 50 mM Tris HCl pH 8.0, 150 mM NaCl, 5 mM EGTA pH 8.0, 50 mM NaF pH 8.0, 10% glycerol, 1.5 mM MgCl 2 , 1% Triton X-100 containing freshly added protease and phosphatase inhibitors cocktail tablets (Complete protease inhibitor cocktail tablets, PhosStop phosphatase inhibitor cocktail tablets, Roche, Monza, IT). Lysates were clarified by centrifugation at 4°C and protein concentrations were determined by Bio-Rad protein assay reagent (BioRad Laboratories, Hercules, CA) and confirmed by Coomassie staining.
For immunoprecipitation analyses, aliquots of cellular lysates were incubated with 1 μg polyclonal anti-FAK antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for 1.5 h at 4°C. Immunocomplexes were collected on protein A-sepharose beads. The beads were washed three times with lysis buffer supplemented with 1% NP-40 then boiled for 3 min in sodium dodecyl sulfate (SDS) sample buffer. For Western blot analyses, equal amount of proteins from cell lysates were resolved on 10% polyacrylamide gel electrophoresis (SDS-PAGE) and 
RNA extraction, reverse transcription PCR and real time quantitative PCR (qRT-PCR)
Total RNA was extracted from cultured cells using an RNA extraction kit (NucleoSpin ® RNA II, Machery-Nagel, Germany)
according to the manufacturer's instructions. Single-stranded cDNA was obtained by reverse transcription of 1 μg of total RNA using MMLV-reverse-transcriptase (Promega, MI, Italia). cDNA was amplified by PCR using GoTaq enzyme (Promega, MI, Italia). qRT-PCRs were performed using BioRad-iQ-iCycler with SYBR green fluorophore; the reactions were carried out using iQ™ SYBR ® Green Supermix (BioRad Laboratories, Hercules, CA) in 20 μl volume in a 96-well plate; 40 ng of cDNA was used as template and cycling parameters were 95°C for 3 min followed by 45 cycles of 95°C for 30 s, 60°C for 1 min, 72°C for 30 s, 60°C + 0.5°C for 10 min. Specificity of each amplicon has been determined by melting curve method. Fluorescence intensities were analyzed using the manufacturer's software and relative amounts with respect to the housekeeping gene β-actin were obtained using the 2 − ΔΔCt method. Primer sequences:
E-cadherin sense 5′-gattacgagggcagtggttct-3′, antisense 5′-catgtccgccagcttcttga-3′ (GenBank accession no.NM_009864.2, from 2633 to 2758); MMP9 sense 5′-cccagatgatgggagagaagc-3′, antisense 5′-cacagcgtggtgttcgaatg-3′ (GenBank accession no. NM _ 013599.2, from 182 to 307); HNF4α1 sense 5′-cggcatggatatggccg-3′, antisense 5′-gggacgtgtcattgccca-3′ (GenBank accession no.NM_008261.2, from 141 to 241); Snail-1 sense 5′-gtctgcacgacctgtggaaag-3′, antisense 5′-gttggagcggtcagcaaaag-3′ (GenBank accession no.NM_011427.2, from 604 to 729); fibronectin sense 5′-tgaagtcgcaaggaaacaagc-3′, antisense 5′-tgaacgggaggacacaggg-3′ (GenBank accession no.NM_010233.1, from 1157 to 1282); β-actin sense 5′-accacaccttctacaatgag-3′, antisense 5′-aggtctcaaacatgatctgg-3′ (GenBank accession no. NM_0073932, from 339 to 458).
Results
FAK is activated during the TGFβ-induced EMT
In the attempt to clarify the role of FAK signaling in TGFβ-mediated EMT of hepatocytes, we first investigated the kinetics of activation of this kinase in response to TGFβ. The FAK phosphorylation levels on Tyr-861 (in the Cterminal domain), Tyr-577 (in the activation loop of the catalytic domain) and Tyr-925 (in the Grb2 SH2-binding site) were analyzed by using anti-phospho-specific antibodies. In fact, while FAK has been described to have multiple tyrosine phosphorylation sites, Tyr-861, Tyr-577 and Tyr-925 have been previously correlated to EMT, migration and tumorigenesis [21, 26] . As shown in Fig. 1A , we found that 15 min of TGFβ treatment was sufficient to increase FAK basal phosphorylation at Tyr-861 and Tyr-925 residues. The activation persisted for 24 h, when the cells underwent a complete EMT ( Fig. 2A ; [22] ). On the contrary the level of Tyr-577 phosphorylation did not significantly change in comparison to that of untreated cells (Fig. 1A) . Furthermore, immunostaining analyses showed that FAK translocated to newly formed TGFβ-induced focal adhesions, co-localizing with the focal adhesion marker Paxillin (Fig. 1B) .
Since phosphorylation of both Tyr-861 and Tyr-925 residues has been described to be mediated by the Src family kinases [27] , we treated MMH cells with the Src inhibitor PP2 demonstrating that the TGFβ-mediated FAK activation required Src activity (Fig. 1C) .
These results demonstrate that (i) FAK is activated by TGFβ in an Src-dependent manner and (ii) FAK localizes in TGFβ-induced focal adhesions in hepatocytes undergoing EMT.
Interfering with FAK signaling does not block TGFβ-induced phenotypic transition and E-cadherin transcriptional down-regulation
In order to determine the role of FAK signaling in TGFβ-induced EMT, we stably expressed in MMHs the dominant negative inhibitor of FAK function named FRNK ( [28] , MMH-FRNK). As a control, we used both parental cells and MMH overexpressing a mutated FRNK protein FRNK-S1034 that is not able to localize to the focal adhesions and therefore does not function as a dominant negative (MMH-S1034). Several clones were obtained and analysis was carried out on MMH cells, two MMH-FRNK and one MMH-S1034 clones. First, we analyzed whether FRNK interfered with TGFβ-induced EMT. As shown in Fig. 2A , MMH cells and MMH-S1034 cells acquired a fibroblastic phenotype after 24 h of TGFβ treatment. After the same time of TGFβ treatment MMH-FRNK cells, while appeared less dispersed than MMH cells and MMH-S1034, still showed a elongated phenotype. The latter observation indicated that TGFβ was able to induce a phenotypic transition resembling an EMT also in hepatocytes with impaired FAK function. Furthermore, quantitative qRT-PCR analyses showed that in MMH-FRNK cells TGFβ was able to transcriptionally up-regulate Snail; this, in turn, caused a clear drop in the transcript levels of the Snail major target gene Ecadherin (Fig. 2B) . When MMH hepatocytes were treated only with Src inhibitor PP2 cell-cell contacts appeared tighter, as previously reported for other cell systems (Fig. 2C, [16] ). Notably, cells treated with both TGFβ and PP2 became elongated (Fig. 2C) , up-regulated Snail mRNA and, conversely, down-regulated E-cadherin mRNA (Fig. 2D) . These results suggest that Src/FAK signaling is not required during TGFβ-induced EMT of the hepatocytes (i) to regulate the expression of the EMT master gene Snail and (ii) to modulate the expression of the Snail target gene E-cadherin.
FAK signaling is required for TGFβ-induced up-regulation of mesenchymal markers during MMH cells EMT
We next asked whether Src-FAK signaling could play a role in TGFβ-induced up-regulation of mesenchymal and invasiveness markers. We analyzed the modulation of expression of the mesenchymal marker fibronectin and of MMP-9 in MMH-FRNK and MMH-S1034 cell clones, treated or not with TGFβ. MMP-9 and fibronectin are both defined as hallmarks of EMT and are modulated by TGFβ, but not by Snail, in MMH cells [22] . qRT-PCR analysis showed that, in the presence of TGFβ, the expression of fibronectin and MMP9 was not significantly upregulated in MMH-FRNK clones compared to MMH-S1034 and MMH cells (Fig. 3A) . Moreover, Src inhibitor PP2 abolished TGFβ-induced up-regulation of MMP-9 and fibronectin expression in MMH cells (Fig. 3B) . This evidence suggests a significant role for mesenchymal phenotype acquisition in hepatocytes through Src/FAK signaling.
FAK signaling is required in hepatocytes for TGFβ-induced delocalization and degradation of E-cadherin
The observation that Src signaling activation may trigger internalization and degradation of E-cadherin [29] leads us to hypothesize that Src/FAK could also have a similar role in TGFβ-mediated EMT. To address this point we compared membrane-bound E-cadherin in MMH-FRNK, in MMH-S1034 and in PP2-treated MMH cells undergoing an EMT. In order to rule out the possibility that the decrease of membrane-bound E-cadherin could be the result of a transcriptional downregulation, the analyses were carried out at 12 h. In fact, in our experimental cell system, a time course of TGFβ treatment showed that E-cadherin transcriptional repression was detectable only after 24 h, while the onset of Snail expression was observed as early as 1 h and HNF4α started to decline after 4 h (Fig. 4A) .
As shown in Fig. 4B, 12 h of TGFβ treatment caused the expected morphological change as well as nuclear HNF4α down-regulation in all the three cell lines, thus providing evidence for a TGFβ-induced transition. Notably, in the meantime the E-cadherin staining continued to decorate the cellular membrane both in MMH-FRNK and in PP2-treated MMHs (Fig. 4B) . Furthermore, Western blot analyses showed that, after 12 h of TGFβ treatment, E-cadherin levels were decreased in MMH-S1034 cells but were unmodified in MMH-FRNK and PP2-treated cells (Fig. 4C) . These data indicated that in hepatocytes Src/FAK signaling is required during TGFβ-induced EMT for E-cadherin membrane delocalization and degradation.
Discussion
Our main finding is that TGFβ-induced EMT requires an Srcmediated FAK activation for (i) transcriptional up-regulation of mesenchymal and invasiveness markers (i.e. MMP9 and fibronectin) and (ii) delocalization of membrane-bound Ecadherin. To our knowledge, our results provide the first evidence of a specific FAK functional role in TGFβ-mediated EMT of the hepatocyte. Here, we show that after TGFβ treatment FAK (i) is activated by Src-dependent phosphorylation on specific 861 and 925 tyrosines and (ii) is localized to focal adhesions of hepatocytes undergoing TGFβ-induced EMT. The impairment of Src/FAK function does not affect TGFβ-mediated Snail activation and E-cadherin transcriptional downregulation but, notably, it impedes the transcriptional upregulation of mesenchymal and invasiveness markers. Our results imply that Src/FAK signaling is necessary for the full accomplishment of the TGFβ-induced EMT in hepatocytes.
It is well established that Src signaling induces a switch in adhesion type predominance from cadherin-to integrin-based adhesions, promoting a more motile phenotype. In fact, the Src signaling pathway is an important component of adhesion changes associated with the EMT in cancer [30] . Since c-Src is activated by TGFβ in various cell types [31, 32] it has been hypothesized that Src pathway is likely a driving force also in TGFβ-mediated EMT, however, previous investigations yielded contradictory results. While Galliher and Schiemannn found that Src-mediated TGFβ receptor type II phosphorylation enhances the EMT [15] , Maeda and colleagues concluded that Src activation is not necessary for this process [16] . These discrepancies may be ascribed to different EMT readout used by the authors.
Concerning FAK, its Src-dependent activation has been proposed to cause negative regulation of E-cadherin mediated cell-cell contacts [33] , but its role in regulating intercellular adhesion appears more complex. In fact it has been shown that suppression of FAK specific signaling determines a phenotype similar to that of cells over-expressing constitutively activated Src [34] . This discrepancy may be based on differential phosphorylation of FAK, as proposed by Nakamura and co-workers [21] that speculated that different modes and qualities of FAK tyrosine phosphorylation are likely to evoke different downstream signaling cascades. Interestingly, specific FAK phosphorylation on Y925 facilitates the angiogenic switch in tumor progression [26] . Finally, the diversity of responses to Src/FAK-or FAK-induced effects on cell-cell adhesion has been also ascribed to different cell types [30] .
We also observe that E-cadherin transcriptional downregulation is a late event of TGFβ-mediated EMT of hepatocytes, while in early phases the Src/FAK signaling mediates the membrane-bound E-cadherin delocalization and degradation (Figs. 4B and C) . This is in accord with a recent report [35] that highlights the relevance of both transcriptional and posttranslational TGFβ-dependent mechanisms of E-cadherin regulation during tumor progression. Future experiments are required to clarify whether FAK is also involved in the reported Src-mediated E-cadherin delivery to lysosomes [29] and/or ubiquitination/degradation [36] .
Our results provide new insights into the molecular mechanisms underlying TGFβ-induced EMT, unraveling a key role of specific FAK activation in controlling both acquisition of mesenchymal and invasiveness markers as well as destabilization of cell-cell contacts by E-cadherin delocalization.
